In an effort to support the next generation of leading Alzheimer's researchers, the Cure Alzheimer's Fund has joined with the Alzheimer's Association and the Lou Ruvo Brain Institute to create and fund a new "genius grant" for young Alzheimer's researchers.
Cure Alzheimer’s Fund researcher, Dr. Rudy Tanzi, briefed Congress on the progress of the fast track effort to map genes for Alzheimer’s disease.
Dr. David Holtzman, a member of Cure Alzheimer’s Fund Research Consortium, received the prestigious MetLife Foundation Award for Medical Research in Alzheimer’s Disease.
In recognition of his groundbreaking genetic research and outstanding leadership and commitment to finding a cure for Alzheimer’s disease, Dr. Rudolph Tanzi received the 2007 Ronald and Nancy Reagan Award at the Alzheimer’s Association’s National Gala in Washington DC on March 27, 2007.
Massachusetts General Hospital and the MassGeneral Institute for Neurodegenerative Disease (MIND) has honored Cure Alzheimer’s Fund for its leadership, entrepreneurial philanthropy and investment in research projects that have the highest probability of slowing, stopping or reversing Alzheimer’s disease.
Washington – With more than 5 million Americans now living with Alzheimer’s disease, a 10 percent increase since 2002, medical researchers are in a sprint to map and sequence the genes susceptible to Alzheimer’s in hopes of leading to more aggressive therapeutic interventions to slow, stop or even reverse the effects of the disease.
Washington – In recognition of his groundbreaking genetic research and outstanding leadership and commitment to finding a cure and better treatment for Alzheimer’s disease, Dr. Rudolph Tanzi received the 2007 Ronald and Nancy Reagan Award at the Alzheimer’s Association’s National Gala this week.
Boston – Massachusetts General Hospital (MassGeneral) has honored Cure Alzheimer’s FundTM for its leadership, entrepreneurial philanthropy and investment in research projects that have the highest probability of slowing, stopping or reversing Alzheimer's disease. The first annual Award for “Philanthropic Innovation and Investment” was presented to the Fund by MassGeneral’s Institute for Neurodegenerative Disease, at a ceremony at Massachusetts General Hospital on Friday, March 2.
First-of-its-Kind Online Resource (ww.alzgene.org) Offers Researchers an Extensive Database of Studies on the Genes Associated with Alzheimer's Risk
Boston, MA – AlzGene, a web-based clearinghouse for researchers working to unlock the genetic makeup of Alzheimer’s Disease, has been launched as a way to gather and analyze studies by and for investigators around the world. The project aims to bring clarity to the increasingly prolific and confusing field of Alzheimer’s genetics research.
Paper describing the development and function of the AlzGene database of genetic studies in Nature Genetics. Project is first of its kind.
© 2005-2014 Cure Alzheimer's Fund. All rights reserved.